Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 5
97
Views
0
CrossRef citations to date
0
Altmetric
Research Article

MiR-494-mediated Effects on the NF-κB Signaling Pathway Regulate Lipopolysaccharide-Induced Acute Kidney Injury in Mice

, , , , &

References

  • An X, Shang F. 2018. RA-XII exerts anti-oxidant and anti-inflammatory activities on lipopolysaccharide-induced acute renal injury by suppressing NF-kappaB and MAPKs regulated by HO-1/Nrf2 pathway. Biochem Biophys Res Commun. 495(3):2317–23.
  • Cheng W, Hao CY, Zhao S, Zhang LL, Liu D. 2019. SNHG16 promotes the progression of osteoarthritis through activating microRNA-93-5p/CCND1 axis. Eur Rev Med Pharmacol Sci. 23(21):9222–29.
  • Choi M, Schreiber A, Eulenberg-Gustavus C, Scheidereit C, Kamps J, Kettritz R. 2017. Endothelial NF-kappaB blockade abrogates ANCA-Induced GN. J Am Soc Nephrol. 28:3191–204.
  • Christaki E, Anyfanti P, Opal SM. 2011. Immunomodulatory therapy for sepsis: an update. Expert Rev Anti Infect Ther. 9(11):1013–33.
  • Council NR. 2011. Guide for the care and use of laboratory animals, 8th ed. Washington (DC): The National Academies Press.
  • Dutta P, Haller E, Sharp A, Nanjundan M. 2016. MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes. BMC Cancer. 16(1):33.
  • Geng L, Zhang T, Liu W, Chen Y. 2018. miR-494-3p modulates the progression of in vitro and in vivo Parkinson’s disease models by targeting SIRT3. Neurosci Lett. 675:23–30.
  • Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, Boer W, De Waele E, Collin V, Spapen HD. 2011. Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments. Ann Intensive Care. 1(1):32.
  • Islam MS, Miao L, Yu H, Han Z, Sun H. 2019. Ethanol extract of illicium henryi attenuates LPS-induced acute kidney injury in mice via regulating inflammation and oxidative stress. Nutrients. 11(6):1412.
  • Khajevand-Khazaei MR, Azimi S, Sedighnejad L, Salari S, Ghorbanpour A, Baluchnejadmojarad T, Mohseni-Moghaddam P, Khamse S, Roghani M. 2019. S-allyl cysteine protects against lipopolysaccharide-induced acute kidney injury in the C57BL/6 mouse strain: involvement of oxidative stress and inflammation. Int Immunopharmacol. 69:19–26.
  • Lan YF, Chen HH, Lai PF, Cheng CF, Huang YT, Lee YC, Chen TW, Lin H. 2012. MicroRNA-494 reduces ATF3 expression and promotes AKI. J Am Soc Nephrol. 23(12):2012–23.
  • Lee H, Jee Y, Hong K, Hwang GS, Chun KH. 2013. MicroRNA-494, upregulated by tumor necrosis factor-alpha, desensitizes insulin effect in C2C12 muscle cells. PLoS One. 8(12):e83471.
  • Lin Y, Ding Y, Song S, Li M, Wang T, Guo F. 2019. Expression patterns and prognostic value of miR-210, miR-494, and miR-205 in middle-aged and old patients with sepsis-induced acute kidney injury. Bosn J Basic Med Sci. 19(3):249–56.
  • Ling Y, Li ZZ, Zhang JF, Zheng XW, Lei ZQ, Chen RY, Feng JH. 2018. MicroRNA-494 inhibition alleviates acute lung injury through Nrf2 signaling pathway via NQO1 in sepsis-associated acute respiratory distress syndrome. Life Sci. 210:1–8.
  • Liu B, Wu Y, Wang Y, Cheng Y, Yao L, Liu Y, Qian H, Yang H, Shen F. 2018. NF-kappaB p65 Knock-down inhibits TF, PAI-1 and promotes activated protein C production in lipopolysaccharide-stimulated alveolar epithelial cells type II. Exp Lung Res. 44(4–5):241–51.
  • Liu P, Jia SB, Shi JM, Li WJ, Tang LS, Zhu XH, Tong P. 2019a. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis. Biosci Rep. 39(5):BSR20181469.
  • Liu X, Lu J, Liao Y, Liu S, Chen Y, He R, Men L, Lu C, Chen Z, Li S, et al. 2019b. Dihydroartemisinin attenuates lipopolysaccharide-induced acute kidney injury by inhibiting inflammation and oxidative stress. Biomed Pharmacother. 117:109070.
  • Ma J, Li YT, Zhang SX, Fu SZ, Ye XZ. 2019. MiR-590-3p attenuates acute kidney injury by inhibiting tumor necrosis factor receptor-associated factor 6 in septic mice. Inflammation. 42(2):637–49.
  • Matejovic M, Valesova L, Benes J, Sykora R, Hrstka R, Chvojka J. 2017. Molecular differences in susceptibility of the kidney to sepsis-induced kidney injury. BMC Nephrol. 18(1):183.
  • Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, et al. 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 278(5339):860–66.
  • Meyer-Schwesinger C, Dehde S, von Ruffer C, Gatzemeier S, Klug P, Wenzel UO, Stahl RA, Thaiss F, Meyer TN. 2009. Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling. Am J Physiol Renal Physiol. 296(5):F1088–1099.
  • Mir SM, Ravuri HG, Pradhan RK, Narra S, Kumar JM, Kuncha M, Kanjilal S, Sistla R. 2018. Ferulic acid protects lipopolysaccharide-induced acute kidney injury by suppressing inflammatory events and upregulating antioxidant defenses in Balb/c mice. Biomed Pharmacother. 100:304–15.
  • Parmar A, Langenberg C, Wan L, May CN, Bellomo R, Bagshaw SM. 2009. Epidemiology of septic acute kidney injury. Curr Drug Targets. 10(12):1169–78.
  • Plotnikov EY, Pevzner IB, Zorova LD, Chernikov VP, Prusov AN, Kireev II, Silachev DN, Skulachev VP, Zorov DB. 2019. Mitochondrial damage and mitochondria-targeted antioxidant protection in LPS-induced acute kidney injury. Antioxidants (Basel). 8(6):176.
  • Ren GL, Zhu J, Li J, Meng XM. 2019. Noncoding RNAs in acute kidney injury. J Cell Physiol. 234(3):2266–76.
  • Ries J, Baran C, Wehrhan F, Weber M, Motel C, Kesting M, Nkenke E. 2019. The altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue vary from those of the whole blood of OSCC patients. Cancer Biomark. 24(1):19–30.
  • Senouthai S, Wang J, Fu D, You Y. 2019. Fractalkine is involved in lipopolysaccharide-induced podocyte injury through the Wnt/beta-catenin pathway in an acute kidney injury mouse model. Inflammation. 42:1287–300.
  • Shi M, Zeng X, Guo F, Huang R, Feng Y, Ma L, Zhou L, Fu P. 2017. Anti-Inflammatory pyranochalcone derivative attenuates LPS-induced acute kidney injury via inhibiting TLR4/NF-kappaB pathway. Molecules. 22(10):1683.
  • Sordi R, Chiazza F, Johnson FL, Patel NS, Brohi K, Collino M, Thiemermann C. 2015. Inhibition of IkappaB kinase attenuates the organ injury and dysfunction associated with hemorrhagic shock. Mol Med. 21:563–75.
  • Szeto CC. 2014. Urine miRNA in nephrotic syndrome. Clin Chim Acta. 436:308–13.
  • Tang ZP, Zhao W, Du JK, Ni X, Zhu XY, Lu JQ. 2018. miR-494 contributes to estrogen protection of cardiomyocytes against oxidative stress via targeting (NF-kappaB) repressing factor. Front Endocrinol (Lausanne). 9:215.
  • Yao Y, Hu X, Feng X, Zhao Y, Song M, Wang C, Fan H. 2019. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-kappaB pathway. J Cell Biochem. 120(10):18509–23.
  • Ye-Ting Z, Dao-Ming T. 2018. Systemic Inflammatory Response Syndrome (SIRS) and the pattern and risk of sepsis following gastrointestinal perforation. Med Sci Monit. 24:3888–94.
  • Zhang F, Lu S, Jin S, Chen K, Li J, Huang B, Cao Y. 2018. Lidanpaidu prescription alleviates lipopolysaccharide-induced acute kidney injury by suppressing the NF-kappaB signaling pathway. Biomed Pharmacother. 99:245–52.
  • Zhang J, Yang S, Chen F, Li H, Chen B. 2017a. Ginkgetin aglycone ameliorates LPS-induced acute kidney injury by activating SIRT1 via inhibiting the NF-kappaB signaling pathway. Cell Biosci. 7(1):44.
  • Zhang L, Sun D, Bao Y, Shi Y, Cui Y, Guo M. 2017b. Nerolidol protects against LPS-induced acute kidney injury via inhibiting TLR4/NF-kappaB signaling. Phytother Res. 31(3):459–65.
  • Zhang T, Xiang L. 2019. Honokiol alleviates sepsis-induced acute kidney injury in mice by targeting the miR-218-5p/heme oxygenase-1 signaling pathway. Cell Mol Biol Lett. 24:15.
  • Zhao H, Li G, Wang R, Tao Z, Ma Q, Zhang S, Han Z, Yan F, Li F, Liu P, et al. 2020. Silencing of microRNA-494 inhibits the neurotoxic Th1 shift via regulating HDAC2-STAT4 cascade in ischaemic stroke. Br J Pharmacol. 177:128–44.
  • Zheng HZ, Fu XK, Shang JL, Lu RX, Ou YF, Chen CL. 2018. Ginsenoside Rg1 protects rat bone marrow mesenchymal stem cells against ischemia induced apoptosis through miR-494-3p and ROCK-1. Eur J Pharmacol. 822:154–67.
  • Zhou P, Chen Z, Zou Y, Wan X. 2016. Roles of non-coding RNAs in acute kidney injury. Kidney Blood Press Res. 41(6):757–69.
  • Zhou RP, Chen G, Shen ZL, Pan LQ. 2014. Cinobufacin suppresses cell proliferation via miR-494 in BGC- 823 gastric cancer cells. Asian Pac J Cancer Prev. 15(3):1241–45.
  • Zhu Y, Yin X, Li J, Zhang L. 2019. Overexpression of microRNA-204-5p alleviates renal ischemia-reperfusion injury in mice through blockage of Fas/FasL pathway. Exp Cell Res. 381(2):208–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.